Brief: Cosmo Pharmaceuticals H1 EPS EUR -0.279
23/07/2026 06:02
BRIEF-Cosmo Pharmaceuticals H1 EPS EUR -0.279 Jul 23 (Reuters) - Cosmo Pharmaceuticals H1 operating expenses EUR 56.8 million.
- H1 revenue EUR 50.2 million
- outlook FY revenue EUR 105-110 million vs. IBES estimate EUR 107.4 million
Recent news on Cosmo NV
See all newsFocus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
Ireland's Cosmo recurring revenue rises on winlevi growth, reaffirms FY guidance
Brief: Cosmo Pharmaceuticals H1 EPS EUR -0.279
Cosmo Pharma's male hair loss treatment shows sustained hair growth in year‑long study
Europe Research Roundup: Airbus ,Bechtle, Salzgitter